Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. The company is headquartered in Atlanta, Georgia and currently employs 2,860 full-time employees. The company went IPO on 2020-06-29. The firm's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
Follow-Up Questions
Who is the CEO of Mirion Technologies Inc?
Mr. Thomas Logan is the Chairman of the Board of Mirion Technologies Inc, joining the firm since 2005.
What is the price performance of MIR stock?
The current price of MIR is $27.52, it has decreased 1.05% in the last trading day.
What are the primary business themes or industries for Mirion Technologies Inc?
Mirion Technologies Inc belongs to Electrical Equipment industry and the sector is Information Technology
What is Mirion Technologies Inc market cap?
Mirion Technologies Inc's current market cap is $6.8B
Is Mirion Technologies Inc a buy, sell, or hold?
According to wall street analysts, 8 analysts have made analyst ratings for Mirion Technologies Inc, including 3 strong buy, 6 buy, 1 hold, 0 sell, and 3 strong sell
